Cargando…

Gut Microbiota: Association with NAFLD and Metabolic Disturbances

Nonalcoholic fatty liver disease is the hepatic expression of metabolic syndrome, being frequently associated with obesity, insulin resistance, and dyslipidemia. Recent lines of evidence have demonstrated a role of gut microbiota in insulin resistance, obesity, and associated metabolic disturbances,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lau, E., Carvalho, D., Freitas, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452311/ https://www.ncbi.nlm.nih.gov/pubmed/26090468 http://dx.doi.org/10.1155/2015/979515

Ejemplares similares

Gut Microbiota and Lifestyle Interventions in NAFLD
por: Houghton, David, et al.
Publicado: (2016)

Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
por: Chen, Jiezhong, et al.
Publicado: (2020)

Nutritional Approach Targeting Gut Microbiota in NAFLD—To Date
por: Moszak, Małgorzata, et al.
Publicado: (2021)

Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions
por: Hrncir, Tomas, et al.
Publicado: (2021)

CONSORT-Characteristics and metabolic phenotype of gut microbiota in NAFLD patients
por: Ge, Haize, et al.
Publicado: (2022)

Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Saeed, Ali, et al.
Publicado: (2017)

The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
por: Song, Qian, et al.
Publicado: (2022)

Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD
por: Jiang, Xiaofan, et al.
Publicado: (2020)

Current Research on the Pathogenesis of NAFLD/NASH and the Gut–Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome
por: Kobayashi, Takashi, et al.
Publicado: (2022)

Thioredoxin/Glutaredoxin Systems and Gut Microbiota in NAFLD: Interplay, Mechanism, and Therapeutical Potential
por: Zhu, Minghui, et al.
Publicado: (2023)

Disturbances of the Gut Microbiota and Microbiota-Derived Metabolites in Inflammatory Bowel Disease
por: Hu, Yongjia, et al.
Publicado: (2022)

The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD
por: Soderborg, Taylor K., et al.
Publicado: (2018)

Meta-Omic Platforms to Assist in the Understanding of NAFLD Gut Microbiota Alterations: Tools and Applications
por: Del Chierico, Federica, et al.
Publicado: (2014)

Dysregulated hepatic lipid metabolism and gut microbiota associated with early-stage NAFLD in ASPP2-deficiency mice
por: Xie, Fang, et al.
Publicado: (2022)

Microbiota, Fiber, and NAFLD: Is There Any Connection?
por: Pérez-Montes de Oca, Alejandra, et al.
Publicado: (2020)

Fecal Microbiota Transplantation in NAFLD Treatment
por: Abenavoli, Ludovico, et al.
Publicado: (2022)

Gut Microbiota-Derived Components and Metabolites in the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Ji, Yun, et al.
Publicado: (2019)

Diet and Gut Microbiota Interaction-Derived Metabolites and Intrahepatic Immune Response in NAFLD Development and Treatment
por: Yang, Ming, et al.
Publicado: (2021)

Cannabis Extract Effects on Metabolic Parameters and Gut Microbiota Composition in a Mice Model of NAFLD and Obesity
por: Zandani, Gil, et al.
Publicado: (2022)

The Positive Effects of Grifola frondosa Heteropolysaccharide on NAFLD and Regulation of the Gut Microbiota
por: Li, Xin, et al.
Publicado: (2019)

The identification of metabolites from gut microbiota in NAFLD via network pharmacology
por: Oh, Ki-Kwang, et al.
Publicado: (2023)

Chlorogenic Acid Improves NAFLD by Regulating gut Microbiota and GLP-1
por: Shi, Ameng, et al.
Publicado: (2021)

Author Correction: The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD
por: Soderborg, Taylor K., et al.
Publicado: (2019)

Dietary Components That May Influence the Disturbed Gut Microbiota in Chronic Kidney Disease
por: Mafra, Denise, et al.
Publicado: (2019)

The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD
por: Perumpail, Brandon J., et al.
Publicado: (2019)

Analysis of the developing gut microbiota in young dairy calves—impact of colostrum microbiota and gut disturbances
por: Hang, Bui Phan Thu, et al.
Publicado: (2020)

Modulation of Gut Microbiota and Metabolites by Berberine in Treating Mice With Disturbances in Glucose and Lipid Metabolism
por: Fang, Xinyi, et al.
Publicado: (2022)

Role of gut microbiota in metabolic syndrome: a review of recent evidence
por: Alveirinho, Manuel, et al.
Publicado: (2020)

The Metabolism of Glucosinolates by Gut Microbiota
por: Sikorska-Zimny, Kalina, et al.
Publicado: (2021)

Comorbidities and Metabolic Derangement of NAFLD
por: Bang, Ki Bae, et al.
Publicado: (2015)

Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet
por: Machado, Mariana Verdelho, et al.
Publicado: (2016)

Gut microbiota and metabolic syndrome
por: Wang, Peng-Xu, et al.
Publicado: (2020)

Effect of Sheng-Jiang Powder on Gut Microbiota in High-Fat Diet-Induced NAFLD
por: Li, Juan, et al.
Publicado: (2020)

Akkermansia muciniphila and Bifidobacterium bifidum Prevent NAFLD by Regulating FXR Expression and Gut Microbiota
por: Nian, Fulin, et al.
Publicado: (2023)

Gut microbiota disorders cause type 2 diabetes mellitus and homeostatic disturbances in gut-related metabolism in Japanese subjects
por: Adachi, Kazunori, et al.
Publicado: (2019)

The Link between NAFLD and Metabolic Syndrome
por: Radu, Fabiana, et al.
Publicado: (2023)

Involvement of the microbiota-gut-brain axis in chronic restraint stress: disturbances of the kynurenine metabolic pathway in both the gut and brain
por: Deng, Yuanyuan, et al.
Publicado: (2021)

Resveratrol, Metabolic Syndrome, and Gut Microbiota
por: Chaplin, Alice, et al.
Publicado: (2018)

Rotundic Acid Protects against Metabolic Disturbance and Improves Gut Microbiota in Type 2 Diabetes Rats
por: Yan, Zenghao, et al.
Publicado: (2019)

Role of microbiota and related metabolites in gastrointestinal tract barrier function in NAFLD
por: Fernandez-Cantos, Maria Victoria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m1n027ncgqq1sflk3touncr5gf